SEC Form 4 · accession 0000899243-16-023237
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rong Zhou
Officer — EVP, Production Center
Period of report
Jun 15, 2016
Accepted (ET)
Jun 17, 2016 · 6:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 15, 2016 | S | 1,551 | $15.8503 | D | 37,137 | D | |
| Common StockF3 | Jun 15, 2016 | F | 146 | $15.76 | D | 36,991 | D | |
| Common StockF4 | holding | — | — | — | 99,668 | I | See footnote | |
| Common StockF5 | holding | — | — | — | 5,000 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.82 to $15.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of deferred stock units, or DSUs.
- F4The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.
- F5The shares are held of record by the reporting person's spouse.